FDA Approves Darolutamide Tablets for Select Patients with Prostate Cancer

by admin_63069 | Aug 26, 2022 | Articles of Interest

Patients with hormone-sensitive prostate cancer who received darolutamide in combination with docetaxel experienced superior overall survival and time-to-pain progression benefit.